The role of renin-angiotensin system in patients with left ventricular assist devices - Alexandros Briasoulis, Ernesto Ruiz Duque, Dimitrios Mouselimis, Anastasios Tsarouchas, Constantinos Bakogiannis, Paulino Alvarez, 2020
C domain-selective inhibition of angiotensin-converting enzyme - Mario R Ehlers, J Albert Abrie, Edward D Sturrock, 2013
Renin-Angiotensin-Aldosterone System Activation During Decongestion in Acute Heart Failure: Friend or Foe?∗ | JACC: Heart Failure
Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study | SpringerLink
Renin-angiotensin-aldosterone system inhibitors - Knowledge @ AMBOSS
Antifibrotic Roles of RAAS Blockers: Update | SpringerLink
What is the Renin-Angiotensin-Aldosterone System?
IJMS | Free Full-Text | Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
Drugs targeting the renin–angiotensin–aldosterone system | Nature Reviews Drug Discovery
Novel RAAS agonists and antagonists: clinical applications and controversies | Nature Reviews Endocrinology
Frontiers | Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea | PLOS ONE
The RAAS in the pathogenesis and treatment of diabetic nephropathy | Nature Reviews Nephrology
Angiotensin II Receptor Blockers in Heart Failure
Renin–Angiotensin–Aldosterone System Inhibitors in Covid-19 | NEJM
Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis - Upinder Kaur, Sankha Shubhra Chakrabarti, Tejas K. Patel, 2021
What Is a Angiotensin Receptor Blocker?
Frontiers | The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction | CFR Journal
Angiotensin Inhibitors and Blockers for Treating Hypertension - Physiopedia
Dual RAAS blockade is desirable in kidney disease: Con - ScienceDirect
Combining incretin-based drugs and RAAS inhibitors: more cons than pros? - The Lancet Diabetes & Endocrinology
Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease - ScienceDirect
Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions
IJMS | Free Full-Text | Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
